Track the evolution of major financial and economic events
Yung-Yu Ma from PNC warned that the worst-case scenario regarding the Iran war escalation has not yet been priced into the market. Meanwhile, investors hope for a rally similar to last April. However, indicators like the Buffett Indicator suggest a potential stock market crash in the U.S. due to slowing growth and geopolitical turmoil. Additionally, U.S. Treasury Secretary Scott Bessent stated that the Fed should adopt a wait-and-see approach before deciding on interest rate cuts.
Sysco Corporation plans to acquire Jetro Restaurant Depot in a massive $29 billion deal. The deal is expected to increase Sysco's revenue by 20% and free cash flow by 55%. It aims to expand Sysco's footprint in the cash-and-carry model and target smaller restaurants.
PepsiCo suffered a loss of approximately $50 billion in market value due to a 50% increase in Doritos prices over a four-year period. Despite the decline in market value, the company delayed taking corrective action as a result of price hikes during the pandemic.
Levi Strauss raised its annual sales and profit forecasts after beating first-quarter estimates. The growth is attributed to resilient demand for premium denim and strength in the direct-to-consumer business. Strong performance helped offset the negative impact resulting from U.S. tariffs.
On April 7, Antares' Mark-0 reactor received the first-ever approval from the U.S. Department of Energy for a Documented Safety Analysis (DSA) under the new DOE-STD-1271 standard. This approval is considered equivalent to a Nuclear Regulatory Commission (NRC) license. BWXT is also completing TRISO fuel fabrication for the pilot, with a planned criticality date before July 4.
On April 7, Ecopetrol's board ousted CEO Ricardo Roa following allegations of influence peddling and campaign finance violations. Juan Carlos Hurtado, the current COO, will serve as interim CEO until June 28. The investigations are linked to Gustavo Petro's 2022 presidential campaign.
On April 7, the Kurdistan Democratic Party of Iran (KDPI) denied receiving weapons from the US, calling the reports baseless. On the same day, US President Donald Trump admitted in a Fox News interview that the US attempted to ship 'a lot of guns' to anti-government protesters in Iran. Israeli media reports also suggested that Mossad agents were on the ground in Iran to organize armed groups ahead of a US-Israeli bombing campaign on February 28.
Nomura predicts that Japanese authorities are likely to intervene in the currency market to support the Yen if USD/JPY reaches the 161 to 163 range. Japanese authorities have stepped up verbal intervention after USD/JPY briefly rose above 160. Middle East tensions and high crude oil prices are contributing to persistent upward pressure on USD/JPY. The Yen may find near-term support if the BOJ branch managers’ meeting increases the likelihood of an April rate hike.
Pakistan is set to repay a $3.5 billion loan to the UAE this month, increasing pressure on its foreign exchange reserves. The $7 billion IMF program requires maintaining reserves above $18 billion by June, while current reserves stand at $16.4 billion. Additionally, there is a $1.3 billion Eurobond repayment due by June. Meanwhile, a Pakistani military force has arrived at King Abdulaziz Air Base in Saudi Arabia as part of a strategic defense pact, and Saudi Arabia and Qatar will provide Pakistan with $5 billion in financial assistance to support its dwindling reserves.
AstraZeneca achieved positive Phase 3 trial results for its drug Imfinzi in treating liver cancer. The drug is expected to become a 'super-blockbuster' and a major growth driver for the company. The treatment targets cases where tumors cannot be surgically removed, a category with historically limited options.
The UK services sector has experienced a sharp decline in sentiment due to rising operating costs driven by the Iran conflict. Companies reported significant cost increases and a drop in demand, exacerbating economic pressures. House prices have fallen, and mortgage rates have risen, impacting the market overall.
On April 7, U.S. lawmakers proposed a law that would impose new export restrictions on semiconductors to China. These restrictions specifically target ASML's deep ultraviolet (DUV) lithography machines. Following the announcement of these legislative proposals, ASML shares fell.
On April 7, Saudi air defenses intercepted 7 missiles targeting the kingdom, raising supply concerns. Critical energy facilities were damaged, leading to a reduction in the kingdom's oil production capacity by about 600,000 barrels per day. On April 14, the SATORP refinery was shut down after being damaged, while US forces were prepared to strike Iran if necessary. On April 17, Iran confirmed targeting oil facilities including in Saudi Yanbu.
France's debt crisis deepens as the budget deficit is projected to stabilize at around 5% by 2026. Total French public debt has reached approximately 115% of GDP. Public spending in France accounts for 57% of GDP as the state apparatus continues to expand.
Citigroup is expected to report Q1 2026 earnings on April 14, with an EPS forecast of $2.60, while analysts anticipate JPMorgan Chase to post an EPS of $5.50 and revenue of $48.30 billion on the same day. Both banks maintain a 'Moderate Buy' rating despite recent insider selling reports. Meanwhile, Simply Good Foods is set to release its Q2 earnings on April 9, with an EPS expectation of $0.40, down from last year's figures.
Sanofi reported positive phase 2 results for Lunsekimig in asthma and nasal polyps. The AIRCULES phase 2b study met its primary and key secondary endpoints in moderate-to-severe asthma regardless of biomarker status. The DUET phase 2a study also met its primary and key secondary endpoints in chronic rhinosinusitis with nasal polyps. However, the exploratory VELVET phase 2b study did not meet its primary endpoint in moderate-to-severe atopic dermatitis.
On April 7, Blue Owl Capital's stock price dropped to $8.45, a significant decline from its all-time high of $25. This sharp decline has erased billions of dollars in market value for the company. The decline is linked to growing concerns regarding the stability of the private credit industry.
Samsung forecasts more than an eightfold increase in first-quarter operating profit. This growth is primarily driven by the semiconductor business and strong demand for AI-related chips.
The private credit sector is facing mixed redemption pressures, with Blue Owl (OWL) shares plummeting 68.2% from their peak due to redemptions totaling $5.4 billion. Goldman Sachs' private credit fund received redemption requests for just under 5% of shares in Q1, remaining below its quarterly cap. This surge in redemptions reflects liquidity strains and investor anxiety across the broader private credit sector.
On April 6, the Trump administration announced a 2.48% increase in Medicare Advantage payments for 2027. This final rate is significantly higher than the proposed 0.09% increase in January. The total increase is estimated to be worth over $13 billion for health insurers.
The upward momentum in U.S. markets stalled due to geopolitical tensions related to threats involving Trump and Iran. Investors rapidly withdrew funds from the largest US-listed ETF tracking Indian equities, leading to a significant drop in the NSE Nifty 50 Index. As Trump announced a naval blockade on all ships in the Strait of Hormuz, concerns over the global energy crisis increased, impacting the markets modestly.
Vizsla Silver confirmed the death of nine of its employees in a tragic incident in Concordia, Sinaloa. The incident occurred on April 6, causing significant shock and sorrow in the local community and within the company.
Verizon announced a plan to return approximately $55 billion to shareholders through dividends and share repurchases by the end of 2028. The company also completed its acquisition of Frontier, expanding fiber access to over 30 million homes and businesses. Daniel Schulman has been appointed as the new CEO, and Mark Bertolini as the independent Chair.
On April 6, Ascendis Pharma launched YUVIWEL, the first once-weekly treatment for children with achondroplasia in the U.S. The treatment received orphan drug exclusivity until February 27, 2033. The company has already begun revenue recognition following approval and initiation of therapy for the first patients.
